Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s Basic Consolidated EPS Came In At $-5.2884

0

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) posted annual consolidated EPS of $-5.2884 for the period ended 2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-5.2884.

Basic EPS from continuing operations

The company’s basic EPS from continuing operations for the annual period ended 2015-12-31 came in at $-5.4022 while basic EPS from continuing operations for the three-month period to 2015-12-31 was$-5.4022.

EPS contribution from parent

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) received $-5.2884 basic EPS contribution from its parent company in the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, the parent company contributed EPS of $-5.2884.

Basic net EPS

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) posted basic net EPS of $-5.4022 for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, the company posted basic net EPS of $-5.4022.

Consolidated diluted EPS

The company’s consolidated diluted EPS for the period ended 2015-12-31 was $-5.2884 while consolidated diluted EPS was $-5.2884 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS from continuing operation for the annual period ended 2015-12-31 was $-5.4022. As for the quarter, diluted EPS from continuing operations for the three-month ended 2015-12-31 stood at $-5.4022.

Net diluted EPS

Net diluted EPS was $-5.4022 for the annual period ended 2015-12-31. But net diluted EPS for the quarterly period ended 2015-12-31 stood at $-5.4022.

Diluted EPS from parent

From the parent company, Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) received diluted EPS of $-5.2884

For the annual period ended 2015-12-31, diluted EPS from Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s parent company was$-5.2884. But for the quarter period ended 2015-12-31, diluted EPS contribution from the parent company was $-5.2884.

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s net basic EPS for the annual period ended 2015-12-31 was $-64.8519 and for the quarter period ended 2015-12-31 it was $-64.8519.

For the annual period ended 2015-12-31, the company had average basic shares outstanding of 0.2259 while basic shares outstanding were 0.2259 for the quarter period ended 2015-12-31.

The company’s diluted shares outstanding was 0.2259 for the annual period ended 2015-12-31 is 0.2259. That compared with 0.2259 diluted shares outstanding for the quarter period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)